Alexandra Teixeira
Guimaraes, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Clinical, Analytical, and Echocardiographic Associations of Impaired Cardiorespiratory Fitness After Anthracycline Chemotherapy in Breast Cancer: EPIC Fitness Study.
Journal: Echocardiography (Mount Kisco, N.Y.)
Published: November 25, 2024
Effects of an Easily Implemented Physical Exercise Program on the Ventricular Ejection Fraction of Women with Breast Cancer Undergoing Chemotherapy.
Journal: International journal of environmental research and public health
Published: November 18, 2024
Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: October 09, 2023
The landscape for lipid-nanoparticle-based genomic medicines.
Journal: Nature reviews. Drug discovery
Published: January 10, 2023
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study.
Journal: The Lancet. Oncology
Published: June 22, 2022
Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: December 25, 2014
Gla-rich protein is a potential new vitamin K target in cancer: evidences for a direct GRP-mineral interaction.
Journal: BioMed research international
Published: January 24, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026